Oncode Accelerator
@oncode_accelerator
Utrecht, Utrechthttps://www.oncodeaccelerator.nl Research ServicesOverview
About Oncode Accelerator
Our mission is bold: to collaboratively optimize and accelerate the development of new cancer therapies for the benefit of patients of all ages.
We aim to achieve this by integrating patient data and materials -including patient-derived organoid models- and artificial intelligence at early stages of preclinical therapy development, across four pipelines focused on developing oncology-targeted therapeutics:
- Small molecules,
- Biologics,
- Cell and gene therapies, and
- Therapeutic vaccines.
Our world-class toolbox of state-of-the-art technologies, is available through Demonstrator Projects to anyone globally that has a target of interest and/or a validated hit, and who wishes to advance their asset to a valuable clinical candidate. Ultimately, our integrated approach and top notch infrastructure should result in more effective, personalized cancer therapies. This will bring us closer to our overarching goal: to outsmart cancer and impact lives.
Oncode Accelerator is a public-private partnership that is funded by the Dutch National Growth Fund (NGF). It is a collaboration between six coordinating partners: Leiden University, Leiden University Medical Center, the Netherlands Cancer Institute, Princess Máxima Center, UMC Utrecht and the Oncode Accelerator Foundation.
We aim to achieve this by integrating patient data and materials -including patient-derived organoid models- and artificial intelligence at early stages of preclinical therapy development, across four pipelines focused on developing oncology-targeted therapeutics:
- Small molecules,
- Biologics,
- Cell and gene therapies, and
- Therapeutic vaccines.
Our world-class toolbox of state-of-the-art technologies, is available through Demonstrator Projects to anyone globally that has a target of interest and/or a validated hit, and who wishes to advance their asset to a valuable clinical candidate. Ultimately, our integrated approach and top notch infrastructure should result in more effective, personalized cancer therapies. This will bring us closer to our overarching goal: to outsmart cancer and impact lives.
Oncode Accelerator is a public-private partnership that is funded by the Dutch National Growth Fund (NGF). It is a collaboration between six coordinating partners: Leiden University, Leiden University Medical Center, the Netherlands Cancer Institute, Princess Máxima Center, UMC Utrecht and the Oncode Accelerator Foundation.